119 related articles for article (PubMed ID: 11809983)
41. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
44. Positron emission tomography/computed tomography (PET/CT) and CT for N staging of non-small cell lung cancer.
Vegar Zubović S; Kristić S; Hadžihasanović B
Med Glas (Zenica); 2017 Aug; 14(2):199-203. PubMed ID: 28698537
[TBL] [Abstract][Full Text] [Related]
45. Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer.
Gourcerol D; Scherpereel A; Debeugny S; Porte H; Cortot AB; Lafitte JJ
Eur Respir J; 2013 Nov; 42(5):1357-64. PubMed ID: 23520312
[TBL] [Abstract][Full Text] [Related]
46. The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trial.
van't Westeinde SC; de Koning HJ; Thunnissen FB; Oudkerk M; Groen HJ; Lammers JW; Weenink C; Vernhout R; Nackaerts K; Mali W; van Klaveren RJ
J Thorac Oncol; 2011 Oct; 6(10):1704-12. PubMed ID: 21876458
[TBL] [Abstract][Full Text] [Related]
47. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
48. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease.
Verstegen NE; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
Radiother Oncol; 2011 Nov; 101(2):250-4. PubMed ID: 22056535
[TBL] [Abstract][Full Text] [Related]
49. Costs of non-small cell lung cancer in the Netherlands.
van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
[TBL] [Abstract][Full Text] [Related]
50. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
[TBL] [Abstract][Full Text] [Related]
51. [Positron emission tomography in the Netherlands: need to expand the capacity].
Comans EF; Smit EF
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1817-9. PubMed ID: 12382364
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
[TBL] [Abstract][Full Text] [Related]
53. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
[TBL] [Abstract][Full Text] [Related]
54. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
[TBL] [Abstract][Full Text] [Related]
55. Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography.
van Tinteren H; Hoekstra OS; Smit EF; Verboom P; Boers M;
Control Clin Trials; 2001 Feb; 22(1):89-98. PubMed ID: 11165427
[TBL] [Abstract][Full Text] [Related]
56. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
Geiger GA; Kim MB; Xanthopoulos EP; Pryma DA; Grover S; Plastaras JP; Langer CJ; Simone CB; Rengan R
Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
[TBL] [Abstract][Full Text] [Related]
57. Staging non-small lung cancer with positron emission tomography: diagnostic value, impact on patient management, and cost-effectiveness.
Nosotti M; Castellani M; Longari V; Chella B; Baisi A; Rosso L; Santambrogio L
Int Surg; 2008; 93(5):278-83. PubMed ID: 19943430
[TBL] [Abstract][Full Text] [Related]
58. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
59. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
[TBL] [Abstract][Full Text] [Related]
60. Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.
Søgaard R; Fischer BM; Mortensen J; Højgaard L; Lassen U
Eur J Nucl Med Mol Imaging; 2011 May; 38(5):802-9. PubMed ID: 21210111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
